Results 281 to 290 of about 144,849 (341)

Rapid Serological Detection of Anti‐GM‐CSF Autoantibodies in Autoimmune Pulmonary Alveolar Proteinosis Using a Novel Immunochromatographic Test

Respirology, EarlyView.
We developed a novel ICT with high clinical performance that can distinguish APAP patients from those with other pulmonary diseases. The rapid and simple detection of GMAbs in serum provided a new practical method for the diagnosis of APAP. ABSTRACT Background and Objectives Anti‐GM‐CSF autoantibodies (GMAbs) are essential biomarkers for diagnosing ...
Chika Narita, Kenjiro Shima, Jun‐ichiro Sekiguchi, Yasuyuki Ozeki, Makoto Akiwa, Shohei Koike, Sachiko Yuki, Keiichi Akasaka, Toshiaki Kikuchi, Nobutaka Kitamura, Koh Nakata   +10 more
wiley   +1 more source

Induction Efficacy and Safety of Upadacitinib for Active Crohn's Disease in Japanese Patients: A Multicenter Retrospective Study. [PDF]

JGH Open
Saiki T, Umeno J, Matsuno Y, Kawasaki K, Moriyama T, Takedomi H, Tsuruoka N, Ashizuka S, Takatsu N, Hisabe T, Nozaka Y, Kurahara K, Nakashima M, Furuta Y, Morita M, Kuwaki K, Nishimata N, Kawano S, Nakamura S, Ota K, Harada A, Hirai F, Torisu T, Esaki M, IBD‐Quality Team.   +24 more
europepmc   +1 more source

Sclerosing cholangitis: Liver transplantation [PDF]

, 1989
Marsh, JW, Starzl, TE
core  

Bioengineered Bacterial Vesicles and Biomimetic Hybrids Eliminate Biofilms and Balance the Gut Microbiome

Small, EarlyView.
Biomimetic nanocarriers based on liposomes and Myxobacteria outer‐membrane vesicles (OMVs) are effective antibiotic delivery systems. Hybrids have a higher drug loading and can target intracellular pathogens, while OMVs evade immune clearance. Biomimetic nanoantibiotics effectively eliminate the biofilms of Gram‐negative bacteria. Besides, Myxobacteria
Leila Pourtalebi Jahromi, Benedikt Kronast, Jennifer Munkert, Lorenzo Sana, Marcus Koch, Heike Danzer, Sirka Dormeyer, Shuhan Jiang, Fabian Herrmann, Matthias Weiler, Anna Kashkanova, Vahid Sandoghdar, Mario M. Zaiss, Gregor Fuhrmann   +13 more
wiley   +1 more source

Stool-Based Proteomic Signature for the Noninvasive Classification of Crohn's Disease and Ulcerative Colitis Using Machine Learning. [PDF]

Clin Transl Gastroenterol
Shajari E, Gagné D, Bourassa F, Malick M, Roy P, Noël JF, Gagnon H, Delisle M, Boisvert FM, Brunet M, Beaulieu JF.   +10 more
europepmc   +1 more source

Fibrostricturing Crohn's Disease Is Marked by an Increase in Active Eosinophils in the Deeper Layers

Inge Jacobs, Bo-Jun Ke, Matthias Ceulemans, Jonathan Cremer, André D’Hoore, Gabriele Bislenghi, Gianluca Matteoli, Gert De Hertogh, João Sabino, Marc Ferrante, Séverine Vermeire, Christine Breynaert, Tim Vanuytsel, Bram Verstockt   +13 more
openalex   +1 more source

Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

Small Methods, EarlyView.
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz, Nima Pourafzal, Audrey T. Zhu, Zhongyuan Guo, Ronnie H. Fang, Liangfang Zhang   +5 more
wiley   +1 more source

Association between prenatal exposure to Crohn's disease and offspring psychiatric regulatory disturbances. [PDF]

Acta Obstet Gynecol Scand
Nivins S, Skott E, Giacobini M, Lindqvist D, Gissler M, Sjöberg K, Lavebratt C.   +6 more
europepmc   +1 more source

TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background While tumor necrosis factor (TNF) inhibitors can induce paradoxical reactions, sarcoidosis‐like disease has hardly been reported so far. This study aimed to describe the epidemiological, diagnostic and therapeutic features of TNF inhibitor‐induced sarcoidosis‐like lesions in patients with inflammatory bowel disease.
Zlata Chkolnaia, Benedicte Lebrun‐Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard, Maeva Charkaoui, Guillaume Le Cosquer, Carmen Stefanescu, Melanie Serrero, Laurianne Plastaras, Sophie Vieujean, David Laharie, Philippe Seksik   +12 more
wiley   +1 more source

Baseline Fusobacterium Abundance Predicts Ustekinumab Response in Crohn's Disease: A Prospective Microbiome Cohort Study. [PDF]

Microb Biotechnol
Wang C, Hao Y, Liu Y, He L, Xu S, Zhang M, Wang X, Wang H.   +7 more
europepmc   +1 more source